U.S. Markets closed

Karo Pharma AB (publ) (KARBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.760.00 (0.00%)
At close: 1:43PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.76
BidN/A x N/A
AskN/A x N/A
Day's Range5.76 - 5.76
52 Week Range3.99 - 6.31
Avg. Volume0
Market Cap893.704M
Beta (5Y Monthly)0.15
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Anna Hale appointed CMO at Karo Pharma

    Karo Pharma Aktiebolag (publ) ("Karo") has appointed Anna Hale as the Chief Marketing Officer (CMO) of Karo. The appointment reflects Karo's growth ambitions, fueled by a strategy of geographical expansion and development of its portfolio of consumer healthcare brands, plus the continuous efforts to strengthen and develop Karo's commercial organization.

  • PR Newswire

    Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO

    Karo Pharma Aktiebolag ("Karo") has appointed Matt Roberts as the new Chief Commercial Officer (CCO) of Karo, replacing Magnus Nylén who has decided to pursue opportunities outside of Karo. Matt will start his new position on September 1, 2021.

  • PR Newswire

    Interim Report Q2 2021: Karo Pharma

    April – June